Cleared Traditional

K832567 - ACETAMINOPHEN(PARACETAMOL

K832567 is the FDA 510(k) clearance for ACETAMINOPHEN(PARACETAMOL by Bio-Analytics Laboratories, Inc.. It is a Class 2 Chemistry device (product code LDP) cleared through the Traditional 510(k) pathway after a 41-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1983
Decision
41d
Days
Class 2
Risk

K832567 is an FDA 510(k) clearance for the ACETAMINOPHEN(PARACETAMOL. Classified as Colorimetry, Acetaminophen (product code LDP), Class II - Special Controls.

Submitted by Bio-Analytics Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 12, 1983 after a review of 41 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio-Analytics Laboratories, Inc. devices

Submission Details

510(k) Number K832567 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 1983
Decision Date September 12, 1983
Days to Decision 41 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 88d · This submission: 41d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LDP Colorimetry, Acetaminophen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3030
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - LDP Colorimetry, Acetaminophen

All 30
Devices cleared under the same product code (LDP) and FDA review panel - the closest regulatory comparables to K832567.
ACA ACETAMINOPHEN ANALYTICAL TEST PACK
K842548 · E.I. Dupont DE Nemours & Co., Inc. · Aug 1984
TDX ACETAMINOPHEN
K840941 · Abbott Laboratories · May 1984
ACETAMINOPHER ASSAY KIT
K832045 · Quantimetrix Corp. · Oct 1983
PROCEDURE #430 & REAGENTS FOR ACETAMIN
K822313 · Sigma Chemical Co. · Aug 1982
EMIT-TOX ACETAMINOPHEN ASSAY
K821379 · Syva Co. · May 1982
STANBIO ACETAMINOPHEN TEST SET #0850
K801014 · Stanbio Laboratory · Jun 1980